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Alcoholic vs non-alcoholic fatty liver in rats:
distinct differences in endocytosis and
vesicle trafficking despite similar pathology
Karuna Rasineni1,2, Daniel D. Penrice1,2, Sathish Kumar Natarajan6, Mark A. McNiven4, Benita L. McVicker1,2,
Kusum K. Kharbanda1,2,3, Carol A. Casey1,2,3 and Edward N. Harris5*

Abstract
Background: Non-alcoholic and alcoholic fatty liver disease (NAFLD and AFLD, respectively) are major health
problems, as patients with either condition can progress to hepatitis, fibrosis, and cirrhosis. Although histologically
similar, key differences likely exist in these two models. For example, altered content of several vesicle trafficking
proteins have been identified in AFLD, but their content in NAFLD is unknown. In this study, we compared select
parameters in NAFLD and AFLD in a rat model.
Methods: We fed either Lieber- DeCarli liquid control or alcohol-containing (35 % as calories) diet (AFLD model) or
lean or high-fat (12 or 60 % derived from fat, respectively) pellets (NAFLD model) for 8–10 weeks, n = 8 in each
model. Serum, hepatocytes and liver tissue were analyzed. Liver injury markers were measured in serum, triglyceride
content and endocytosis (binding and internalization of 125I- asialoorosomucoid) was measured in isolated hepatocytes,
and content of selected trafficking proteins (Rab3D, Rab7 and Rab18) were determined in whole liver tissue.
Results: Although liver injury markers and triglyceride content were similar in both models, binding and internalization
of 125I- asialoorosomucoid was significantly impaired in the hepatocytes from AFLD, but not NAFLD, animals. In
addition, protein content of the asialoglycoprotein receptor (ASGPR) and three trafficking proteins, Rab3D, Rab7and
Rab18, were significantly decreased after alcohol, but not high-fat feeding. Levels of protein carbonylation, amount of
glutathione stores, and lipid peroxidation were similar irrespective of the insult to the livers that resulted in fatty liver.
Conclusion: Impairments in protein trafficking in AFLD are likely a direct result of alcohol administration, and not a
function of fatty liver.
Keywords: Alcoholic fatty liver disease (AFLD), RabGTPase proteins, Asialoglycoprotein receptor (ASGPR), Receptormediated endocytosis, Non-alcohol fatty liver disease (NAFLD)

Background
Fatty liver disease is a prevalent health risk in modern
society, can arise from a variety of etiologies, and can
progress to hepatitis, fibrosis, and cirrhosis. A triglyceride content of greater than 5 % in the liver is defined as a fatty liver [1], and there are two primary
types: alcoholic fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). The first is
caused by the consumption of alcohol (ethanol is oxidized by alcohol dehydrogenase to form acetaldehyde
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which feeds into the acetyl-CoA pathway and, when
in excess, undergoes synthesis of long chain fatty
acids) to form triglycerides in hepatocytes [2]. The
second is the over-consumption of a high fat, high
sugar diet in which excess fat is stored in the liver
[3]. NAFLD as a result of a high fat/high sugar diet,
also called a Western diet, is very prevalent (20–30 %
in US population) and it is projected to be the #1
causation for liver transplantation in less than 7 years
[4]. Indeed, NAFLD afflicts 85–90 % of overweight/
obese individuals of the US [5].
Fatty liver arising from either alcohol consumption or
the over-consumption of a high fat/high sugar diet has a
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similar phenotype in that the hepatocytes accumulate
triglycerides. Additionally, both are known to result in
increased injury markers, such as increased serum alanine aminotransferase (ALT), aspartate aminotransferase
(AST) and alkaline phosphatase (ALP). Of interest to
our laboratories is that while there is extensive data from
a variety of laboratories on the biochemical alterations
present in the liver during AFL, little data is present on
any of these parameters in NAFLD models. Previous
studies have focused on the effects of ethanol exposure
which inhibits clathrin-mediated endocytosis by inhibition
of plasma membrane fusion [6] and more specifically on
the asialoglycoprotein receptor (ASGPR) trafficking and
ligand interactions in our lab [7, 8]. Additionally, we have
studied several small Rab-GTPases known to be involved
in vesicle trafficking and show decreased content in livers
of AFLD animals [9]. In the present study we asked
whether these impairments in ASGPR function and RabGTPase content in AFLD would also occur in the setting
of NAFLD.

Methods
Ethanol was purchased from Pharmaco-AAPER (Brookfield, CT). IRDye infrared secondary antibodies (Abs)
and blocking buffer were from Li-COR Biosciences (Lincoln, NE). Protease inhibitor cocktail (P2714-1BTL),
phosphatase inhibitor (p0044), collagenase (type IV), human orosomucoid (α1-acid glycoprotein), and mouse
anti-Rab7 antibody were obtained from Sigma (St. Louis,
MO). The rabbit polyclonal anti-ASGPR antibody was
produced in Dr. Casey’s laboratory and has been described previously [10]. Goat anti-Rab 18 antibody was
from Santa Cruz Biotechnology (Santa Cruz, CA).
Mouse anti-perilipin 2 (anti-PLIN2) antibody was from
Fitzgerald (Acton, MA). Mouse anti-actin antibody was
obtained from Millipore (Billerica, MA). Rab 3D polyclonal antibody was kindly provided by Mark A. McNiven (Mayo Clinic, Rochester, MN). PureLink RNA Mini
Kit and TaqMan Gene Expression Master Mix were purchased from Life Technologies (Grand Island, NY). All
other chemicals were obtained from Sigma Chemical
Co. unless stated otherwise.
Animals, diet administration, hepatocyte isolation and
tissue collection

All animals received humane care in accordance with
the guidelines established by the American Association
for the Accreditation of Laboratory Animal Care (AAALAC) and Animal Research: Reporting of In Vivo Experiments (ARRIVE) [11] . All experimental procedures and
ethical standards involving animals were reviewed and
approved by the Institutional Animal Care and Use
Committees at the Veteran’s Administration NebraskaWestern Iowa Health Care System Research Service
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(IACUC #11-067-07, approved on Aug. 24, 2014), site of
the AFLD studies and University of Nebraska Life Sciences Annex (IACUC #956, approved on Oct. 23, 2013),
site of the NAFLD studies. Male Wistar rats weighing
175 to 200 g were divided into two groups (AFLD and
NAFLD) with 8 pairs in each group to get statistically
relevant data (Student’s paired t Test). As described previously [12] for the AFLD model, rats were pair-fed with
control or EtOH-containing Lieber–DeCarli diets [13]
contained 18 % of total calories from protein, 35 % from
fat, 11 % from carbohydrate, and 36 % from ethanol. In
the control diet, ethanol was replaced isocalorically with
maltodextrin. For the NAFLD model, rats were allowed
ad libitum access to pellet diet and water. Rats in the
HFD group (ResearchDiets #D08060104) were fed a diet
with a caloric formulation of 60 % calories derived from
fat (lard; a mixture of mono-, poly- and unsaturated fatty
acids), 20 % from carbohydrates (corn starch, maltodextrin), and 20 % from protein (Casein) and rats fed a lean
diet (Research Diets #D12450K with a caloric (kcal)
composition of 10.0 % derived from fat (lard), 70 % from
carbohydrates (corn starch, maltodextrin) and 20 % from
protein (Casein). Both NAFLD and AFLD diets were
similar for protein and carbohydrate content with a special care of avoiding sucrose and fructose. These diets
have been proven to induce AFLD and NAFLD symptoms and disease that model human alcohol induced
and non-alcohol induced fatty liver, respectively. Rats in
both alcohol and high fat-diet groups were housed at
AAALAC certified institutions (Omaha VAMC and
UNL) in approved housing facilities and transported to
the laboratories for terminal surgical procedures. Rats in
the NAFLD groups were fed ad libitum throughout the
study; rats in the AFLD group were fed the ethanol diet
ad libitum, and the control rat received an equivalent
amount of diet that its pair-fed ethanol consumed. On
the day of sacrifice, control animals were meal-fed, to
minimize variations in feeding patterns [15]. Rats were
sacrificed in the morning hours eight weeks after the initiation of the diet regimen after being anaesthetized with
4 % isoflurane gas mixed with oxygen in a 0.9 m3 chamber. Blood samples were collected via the axillary artery,
and serum used for analysis. A piece of whole liver was
obtained for histological observation (after knotting a
small portion of a small liver lobe with surgical polyester
thread); the remaining liver was perfused with isotonic
buffers containing collagenase (Type 1 V, Sigma #C5138)
as described previously [14, 15].
Clinical chemistry

The serum profile was measured by a Vetscan chemistry
analyzer (Abaxis, Union City, CA). Serum samples were
loaded on the Mammalian Liver Profile reagent rotor
and read with VetScan VS2 Chemistry Analyzer. The
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Mammalian Liver Profile reagent rotor provided the
quantitative measurements of alanine aminotransferase
(ALT), alkaline phosphatase (ALP), albumin (ALB), bile
acids, and total cholesterol.
Liver histology

Paraffin-embedded liver tissue sections were processed
for hematoxylin/eosin staining and evaluated for steatosis and inflammation.
Immunohistochemistry

Immunohistochemical staining for lipid droplet protein
(PLIN2) was performed as described previously [9].
Briefly, paraffin-embedded liver sections were deparaffinized in xylene and rehydrated in ethanol. Following
deparaffinization, slides were subjected to antigen retrieval process with 10 mM sodium citrate buffer (pH 6)
for 20 min. Sections were incubated overnight with
PLIN2 antibody and followed by staining with appropriate Alexa Fluor secondary antibody. Sections were
mounted with vectashield mounting medium containing
DAPI. Confocal images were acquired using a Zeiss
510META laser scanning confocal microscope.
Triglycerides

The extraction of lipids from hepatocytes was carried
out according to the procedure of Folch and colleagues
[16]. Aliquots of lipid extract were saponified to quantify
the triglycerides (TGs) using the TG diagnostic kit
(Thermo dimethyl adipimidate (DMA) kit; Thermo Electron Clinical Chemistry, Louisville, CO).
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separated from unincorporated Na125I with a PD-10 column and quantified by the Bradford assay.
Measurements of ASOR binding and internalization

Assessment of internalization of ASOR was determined
by a modification of our previous studies [15]. Briefly,
hepatocytes isolated from AFLD and NAFLD animals
were plated in triplicate on collagen coated 24-well
plates at a concentration of 105 cells/well and incubated
at 37 °C with 1.0 μg/mL 125I-ASOR (25nM) for various
periods of time (0, 30, 60, 90 & 120 min). Receptor specificity was measured in replicate wells containing excess
unlabeled ASOR to assess background levels. After each
incubation period, cells were washed with phosphatebuffered saline and the amount of radioactive ligand in
cell lysates was determined and normalized to total cell
lysate protein.
mRNA analysis /Analysis of gene expression

For quantification of mRNA, RNA was isolated from
liver pieces using a PureLink RNA Mini Kit (Invitrogen,
Carlsbad, CA) and was reverse transcribed from 1 μg of
total RNA using oligo-dT primers and the Transkriptor
kit (Roche Applied Science). To determine gene expression levels, real-time PCR reactions were performed
using rat-specific primers from the TaqMan Gene Expression Assay System (Rab3D; catalog # rn00756153; Rab 7,
catalog # rn00592246; Rab18, catalog # rn01526466;
ASGPR, catalog # rn00560750) and samples were analyzed in the 7500 Real Time PCR System (Applied Biosystems, Carlsbad, CA). The ΔΔCt method was used to
determine the fold change using actin for normalization.

Western blot analysis

Liver homogenate (20 %) was prepared in 60 % sucrose
in TE buffer (10 mM Tris–HCL, 1 mM EDTA, pH 7.4)
containing a protease and phosphatase inhibitor cocktail
(Sigma, St. Louis, MO). Liver post-nuclear supernatant
(PNS) fractions were obtained by centrifugation (1000 ×
g) of the homogenate for 10 min. Liver PNS samples
were separated by 12 % SDS-PAGE, blotted on nitrocellulose and proteins were detected with appropriate primary antibodies and then immunoreactive proteins were
visualized and quantified using the Odyssey Infrared
Imager and associated software.
Preparation and labeling of asialoorosomucoid (ASOR)

Human orosomucoid (Sigma, St. Louis, MO) was desialylated by the neuraminidase procedure as described by Oka
and Weigel [17]. 125I-ASOR was prepared by the procedure described previously [15]. Briefly, 125 μg of ASOR in
200 μl of PBS was reacted with 38 μg 1,3,4,6-tetrachloro3α,6α-diphenyl-glycoluril dried oxidizing reagent coated
on the bottom of a glass tube and 0.3 mCi Na125I at room
temperature for 15 min. The labeled ASOR was then

Serum hormone quantification

Metabolic hormones; leptin, amylin and insulin were
measured using the Multiplex MAP Magnetic Beadbased immunoassay kits (Millipore Corp. Billerica, MA).
The assay was conducted according to the manufacturer’s instructions using handheld magnetic separator
block for 96-well flat bottom plates (Millipore, Millipore
Corp) and analyzed using the Luminex 200 system
(Luminex Corp., Austin, TX). All samples were run in
duplicate and standards supplied by the manufacturer
were run on each plate. Mean fluorescence intensity was
analyzed using the BioPlex manager software version 5.0
(Bio-Rad, Hercules, CA) and compared to a standard
curve to calculate the concentrations. Values below the
range of the standard curve were set to the lower limit
of detection.
Selected oxidative stress-related parameters in liver tissue

Pro-oxidant formation was assessed by measuring protein carbonyl content as described [18] using 2, 4-dinitrophenylhydrazine and calculated using an extinction
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coefficient of 22 mM−1 cm−1. In addition, the extent of
lipid peroxidation was assessed by quantitating thiobarbituric acid reactive substances (TBARS) following the procedure of Uchiyama & Mihara [19] using malondialdehyde
(MDA) as a standard. Anti-oxidant defense was quantified
by measuring total and oxidized glutathione (GSSG) using
the enzymatic method [20].
Statistical analysis

The results are expressed as mean ± SEM. Comparison
between control and their respective experimental animals was analyzed using the Student’s t-test. p-values of
<0.05 were considered significant.
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Results
Morphology of liver tissue in alcohol and non-alcohol induced fatty liver

At the outset of these experimental procedures, we confirmed those rats on the Lieber-DeCarli (EtOH) diet and
their cohorts on the high fat diet (HFD) had fatty liver
by H&E staining of the liver tissue (Fig. 1). The increased fat content was also quantitated by measuring
triglyceride content in purified hepatocytes. The amount
of triglyceride was similar between the control groups
for both AFLD and NAFLD animals, and in the alcoholfed and high-fat groups, indicating that induction of
fatty liver by both diets were equivalent (Fig. 1e). PLIN 2

Fig. 1 Triglyceride accumulation in the hepatocytes of control and EtOH-fed rats (a, b) and of lean and HFD rats (c, d). Hematoxylin and Eosin
staining was performed on paraffin sections. Images are representative of each pair-fed group of n = 8. Magnification, 200×. e Quantification of
lipid content in isolated hepatocytes. Hepatocyte TGs were extracted with chloroform: methanol (2:1) and amount of glycerol were measured in
each sample. TG levels were significantly increased in both AFLD and NAFLD rats when compared to their respective controls. Values are means
± SEM, n =8, *p ≤ 0.05

Rasineni et al. BMC Gastroenterology (2016) 16:27

staining (a lipid droplet marker) also revealed increases
in LD accumulation between controls and experimental
groups (Fig. 2).
Comparative serum profiles in NAFLD and AFLD

Serum from each animal was tested for markers of liver
damage using the Liver Profile Rotorary disc (Abaxis).
We measured alkaline phosphatase (ALP) is a marker
for a number of disorders including blocked bile ducts
[21] and some forms of cancer [22], but in our models,
it is a sign of cholangiocyte stress and/or damage. ALP
levels in the experimental animals (EtOH-fed or HFD)
were significantly higher than the matched controls
(Fig. 3a). Alanine aminotransferase (ALT) is an indicator
of hepatocyte cell death [23] was also increased in both
the high-fat groups (Fig. 4b). Bile acids (Fig. 3c) and
cholesterol (Fig. 3d) were significantly higher in the
EtOH-fed rats, but no significant differences were identified between high-fat and lean controls in NAFLD
model. These results suggest that the synthesis of lipids
from alcohol metabolic precursors has a greater impact
on cholesterol biosynthesis than the absorption of fatty
acids and esterification of triglycerides [24, 25]. Levels of
albumin, an abundant serum protein produced by hepatocytes, were not affected in either model (Fig. 3e).
We also analyzed pancreatic hormones level in serum
using the Rat Metabolic Hormone Panel provided by
Milliplex systems. Insulin resistance has been shown to
be associated with NAFLD/AFLD [26–28] and, not
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surprisingly, our NAFLD model demonstrated hyperinsulinemia (Fig. 4a). In contrast, despite similar glucose
levels observed in both control and ethanol rats in the
fed condition (data not shown); insulin levels in the
serum of EtOH-fed rats were lower than the controls. In
NAFLD animals, along with increased insulin in the
serum (Fig 4a), we also observed increased glucose (data
not shown). These values were obtained in fed animals,
and further studies on insulin resistance and determination of HOMA-IR will be important to examine in fasted
animals. Like insulin, amylin is a peptide hormone produced by pancreatic beta cells and is co-secreted with insulin to decrease gastric emptying and increase satiety.
Levels of amylin were unchanged in HF-fed rats suggesting
that pancreatic beta cells are normal. In AFLD rats, the
levels were significantly decreased in the EtOH-fed rats
compared to the dietary control (Fig. 4b). The satiety hormone, leptin, was increased in NAFLD rats and unchanged in AFLD rats (Fig. 4c). These results may be
reflective of the administration of the diet which is ad libitum for NAFLD and calorie restricted for the AFLD diet
or the effects of ingested alcohol on pancreatic function.
Receptor-mediated endocytosis in AFLD versus NAFLD

Next, we focused on hepatocyte endocytosis in the isolated primary cells from the two models. Our previous
work has shown that alcohol impairs multiple aspects of
the process of receptor-mediated endocytosis (RME),
using the ASGPR as a model (8–11, 15). In the present

Fig. 2 PLIN2 staining for lipid droplets: Liver sections from Control and EtOH-fed (a, b) and Lean and HFD(c, d) rats both show increased lipid droplet
accumulation (as identified by PLIN2) when compared to their controls. Images are representative of each pair-fed group of n = 8. Magnification, 400×
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Fig. 3 Liver markers in serum of AFLD/NAFLD rats. The VetScan Liver Profile system for analyzing serum revealed specific changes in enzyme and
molecular markers as indicated. The EtOH-fed and HFD cohorts were compared against their respective dietary controls. Values are means ± SEM,
n =8, *p ≤ 0.05

studies, we used a radiolabeled ligand (1251-Acid glycoprotein or orosomucoid (ASOR)), we found that ASGPR
internalization rates with cargo in AFLD are 50 % of the
control (Fig. 5a), in contrast to NAFLD model in which
endocytosis rates are unchanged between control and
HF-fed rats. Follow-up binding studies at 4 °C, indicate
that the level of surface receptors is lower in AFLD hepatocytes (Fig. 5b), but not in NAFLD hepatocytes.
ASGPR protein and mRNA levels in the AFLD rats were
decreased by about 30 and 45 %, respectively. In NAFLD
rats, ASGPR levels were slightly increased as compared
with the control rats, but these differences were not statistically distinguishable (Fig. 5c & d).

(involved in exocytosis), Rab7 (involved in endocytosis/autophagy) and Rab18 (involved in Golgi-endoplasmic
reticulum transfer). In the current study, we measured content of these proteins in livers of AFLD and NAFLD animals (Fig. 6a). Similar to what we have previously
identified, ethanol treatment significantly decreased the
content of Rab3D (75 %), Rab7 (25 %) and Rab18 (16 %) in
liver (Fig. 6b). mRNA for Rab3D, Rab7 and Rab18 were also
significantly impaired in the alcohol-fed, but not the high
fat, non-alcoholic animals (Fig. 6c). In contrast, HFD animals in the NAFLD model did not show any significant
change in Rab7 and Rab18, and increased Rab3D content.
The mRNA profile for the NAFLD animals reflected the
protein expression (Fig. 6c), and was unchanged.

Vesicle protein trafficking defects in AFLD versus NAFLD

In previous studies, we have identified altered protein content for several Rab GTPases in the alcoholic fatty liver [9].
In particular, we identified decreased content for Rab3D

Oxidant stress and anti-oxidant defenses

Oxidative stress and lipotoxicity are known to occur in
NAFLD [29] and AFLD [30]. In regards to the oxidative
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Fig. 4 Metabolic markers in serum AFLD/NAFLD rats. Serum from AFLD and NAFLD rats was analyzed by the Milliplex Map Rat Metabolic Bead
Panel (Millipore), and compared against their respective dietary controls. Values are means ± SEM, n =8, *p ≤ 0.05

stress in both comparative model systems, we observed
a significant increase in protein carbonyls content,
TBARS (a by-product of lipid peroxidation) and oxidized
glutathione (GSSG) in livers of both ethanol-fed and
high-fed animals compared to their respective controlfed animals (Fig. 7a–d). In contrast, ~25 % lower content
of reduced glutathione (GSH) in livers of both EtOH-fed
and HFD rats compared to their controls was observed.

Discussion
One common classical effect of both chronic alcohol intake and high-fat diet consumption is the presence of a
fatty liver, with similar histology (essentially indistinguishable) between the two types. With the increased incidence of NAFLD in the general population, it will be
important to elucidate differences in mechanisms of
fatty liver pathogenesis between fatty liver induced by alcohol administration (AFLD) as compared to that observed under nutrient-induced high-fat diet conditions.
In this article, we have demonstrated the characteristic
differences of AFLD and NAFLD regarding selected
metabolic parameters and important aspects of membrane trafficking by focusing on some well-identified defects which have been involved in AFLD, and compared
these results with a model of diet-induced fatty liver.
For studies reported here, Wistar rats were administered either alcohol (as 36 % of calories as ethanol, 35 %
as fat, 11 % carbohydrate) in a nutritionally adequate

liquid diet or a high fat diet (60 % of calories from fat,
20 % calories from carbohydrate) for 8 weeks. Thus, the
composition of diet and the calorie intake are different,
but both are well accepted models to induce AFLD and
NAFLD respectively. Moreover, it has been shown that
feeding alcohol (35 %) containing or high fat-fed diets
led to histopathological hepatic changes similar to human AFLD and NAFLD [31, 32]. The mechanisms proposed to play a role in the development of alcoholic
fatty liver involve an increase in the fatty acid synthesis,
decrease in fatty acid oxidation and impaired VLDL secretion [33–36]. In high fat-fed conditions, fatty liver is
believed to follow from the development of insulin resistance, an imbalance between hepatic lipid intake, synthesis, degradation and secretion [37, 38]. Despite the
differences in underlying mechanisms, the pathological
features are the same in both conditions. Thus, we took
an interesting approach to elucidate the metabolic differences and similarities between these diseases. As expected, we observed increased hepatic lipid deposition in
both models and the degree and distribution of lipid
droplets were similar. Further assessment of hepatic
function through the measure of serum enzymes and
metabolites revealed both models showed significantly
higher ALT and ALP when compared to their respective
controls. These increases are expected indicators of liver
damage. AST levels were not measured with the VetScan
chemistry rotor and are not a reliable marker in simple
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Fig. 5 ASGPR mediated endocytosis in fatty liver. a Endocytosis of ASOR. Hepatocytes were allowed to internalize 125I-ASOR at 37 °C and cell
samples were collected at the indicated time points, washed, and radioactivity and protein content determined. Results were calculated by the
means ± SEM, n = 4. Values compared against their respective dietary controls. p* < 0.05. b Binding of 1251-ASOR to hepatocytes. Hepatocytes
were incubated at 0 °C for 60 min with 1 μg/mL 1251-asialo-orosomucoid; specific binding was determined in the presence of 100 fold XS of cold
ASOR. Data are expressed as CPM/μg protein for the various groups and are means ± SEM, n =8; *p ≤ 0.05. c Quantification of ASGP-R protein in
liver. Liver lysates were subjected to WB analysis and quantitative data obtained after normalization with GAPDH. d The mRNA levels of ASGP-R
were measured by qPCR analysis and data were presented after normalization with β-actin. Values represent the fold change compared to
respective controls

steatohepatitis [39]. Serum bile acids were significantly
increased in the ethanol-fed AFLD, but not the high-fat
NAFLD animals when compared to their respective controls. An increase in serum bile acids for the AFLD rats
suggest an intrahepatic cholestasis, similar to what has
been reported for serum profiles of ASH and NASH patients [40–42].
Extra hepatic hormone factors are also known to critically modulate hepatic lipid metabolism. In this study, we
measured insulin, amylin and leptin, all of which are
known to participate in the complex process of energy
homeostasis. In ethanol-fed animals, the pancreatic hormones, insulin and amylin, were found to be significantly

decreased compared to the pair-fed controls. Levels of the
adipocyte hormone, leptin, were not altered in sera of
EtOH-fed animals. The decreased plasma levels of pancreatic hormones (insulin and amylin) likely indicate impaired pancreatic function in the setting of AFLD. In
contrast, NAFLD rats fed with the HFD showed hyperinsulinemia and increased leptin levels compared to the lean
controls. Amylin levels were unchanged between experimental and control animals of the NAFLD group. Hyperinsulinemia and insulin resistance are common in both
diabetes and obesity, and in animal models, Samuel et al.
reported that the ability of insulin to suppress hepatic glucose production is diminished in rats feeding with HFD
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Fig. 6 Quantification of Rab 3D, Rab 7 and Rab18 protein and mRNA content in livers of AFLD and NAFLD rats. a Representative Western Blot
analysis for Rab3D, Rab7 and Rab18 proteins. b Quantitative data were analyzed as intensity units using the Odyssey Infrared Imager associated
software. Results were normalized to β-actin and expressed as percentage of their respective controls. c mRNA expression of Rab GTPases 3D, 7
and Rab18. The mRNA levels of Rabs were measured by real-time PCR. Values represent the fold change compared to respective controls. Significant
decreases in protein content and expression were noted in Rabs 3D, 7 and Rab18 for the AFLD, but not the NAFLD rats. Values are means ± SEM,
n =8, *p ≤ 0.05

for 3 days [43]. Thus, impaired insulin function could lead
to compensatory hyperinsulinemia, where the body attempts to balance the reduced effect of insulin by

producing and releasing more insulin. Along with hyperinsulinemia, we also observed increased leptin levels in
NAFLD, which is likely due to leptin resistance [44, 45].
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Fig. 7 Quantification of selected parameters of oxidative stress and anti-oxidant defenses in livers of AFLD and NAFLD rats. a Protein carbonyls;
(b) TBARS; (c) Oxidized GSH (GSSG) (d) Reduced GSH levels were determined as indicated in the Methods section. Values are means ± SEM, n =8, *
p ≤ 0.05 (compared to their respective controls)

The mechanisms for progression of alcoholic liver diseases are likely multifactorial and include multiple
mechanisms, with impaired protein trafficking as one
likely mechanism. Dr. Casey and her laboratory have
studied the events of impaired RME and its consequences in progression of liver disease by using the hepatocyte specific ASGPR. Chronic ethanol administration
has been shown to alter multiple aspects of the hepatic
RME pathway, including decreases in receptor expression, protein content, ligand binding, ligand internalization and receptor recycling [10, 15, 46, 47]. These
impairments were identified as early as one week of
ethanol administration, and were most prominent in hepatocytes isolated from the centrilobular region of the
liver [48]. Consistent with those previous studies, we report here that ethanol administration showed significant
impairments of 125I-ASOR ligand binding and internalization in hepatocytes from EtOH-fed animals when
compared to controls. In parallel to decreased binding,
we also observed decreases in ASGPR expression and its
content in ethanol-fed rats. In contrast, no difference in
binding or internalization was found in the hepatocytes
isolated from the lean and high-fat animals, indicating
specific alcohol-related impairments to endocytosis by
the ASGPR.
In addition to endocytosis by the ASGPR, we have recently reported that ethanol administration results in

decreased protein levels of several small GTPases known
to play an essential role in controlling membrane trafficking of endo- and exocytic pathways [9]. Importantly,
we showed that protein content of three Rabs known to
be involved in vesicle trafficking, endocytosis and Golgiendoplasmic reticulum transport (Rab3D, Rab7 and Rab
18) were are decreased in after alcohol administration,
while others (Rab 1, 2 and 5) were unaffected. In the
present study we had a particular interest in the Rabs
which were sensitive to alcohol administration, and here,
we show that in the AFLD animals, there was a marked,
75 % decrease in the content of Rab3D GTPase in liver,
along with a significant decrease in Rab3D mRNA. Similarly, protein and mRNA content of Rab7 were also significantly lower in ethanol-fed, but not HFD animals,
and Rab18 content and mRNA showed similar results.
None of these proteins showed significant differences
between the NAFLD groups. All of these Rabs could
play a direct role ASGPR trafficking, which was impaired
in AFLD, but not NAFLD rats. Since increased fat in the
form of lipid droplets in AFLD hepatocytes arise from
ethanol and acetaldehyde metabolism, it is possible that
these key metabolites play a role in altered Rab function.
The appearance of fatty liver in AFLD is in contrast to
NAFLD hepatocytes which accumulate lipid due to mass
action of bulk lipid availability. In simple steatosis without inflammation, which is portrayed by our NAFLD
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animal model, the liver is still relatively healthy and just
beginning to show injury as measured with the ALP and
ALT levels. In this state, the liver may serve as a secondary site for lipid storage due to the metabolism of high
concentrations of free fatty acids absorbed by the small
intestine, packaged into chylomicrons, and delivered in
the lymphatics and blood stream and, ultimately, to the
liver. The trafficking machinery in hepatocytes is still
functional as evidenced by the normal levels of Rabs and
ASGPR activity. We hypothesize that vesicle trafficking
in and out of the cell is normal in NAFLD, but liposome
autophagy and trafficking is impaired due to the toxic effects of ethanol metabolism to the cellular machinery in
AFLD. Follow-up experimentation examining lipiddroplet trafficking in the NAFLD and how that is compared with what is known in AFLD is currently under
investigation.
These findings suggest that even though both AFLD
and NAFLD show the same characteristics of fat accumulation and selected examined parameters of liver
pathology (including increased oxidative stress in both
AFLD and NAFLD models), the impairments in membrane trafficking in the ethanol fed animals is likely a
result of alcohol administration, and not from these
observed changes in high-fat or EtOH-fed rats. In
EtOH-fed conditions, ethanol metabolism, in addition to
promoting fatty acid synthesis, also generates highly reactive acetaldehyde and reactive oxygen species (ROS)
by alcohol dehydrogenase (ADH) and CYP2E1 (cytochrome P450, family 2, subfamily E, polypeptide 1) [49].
Since we observed similar changes in the selected parameters of oxidant stress and anti-oxidant defenses irrespective of the insult to the livers that resulted in fatty
liver, it is likely that the observed differences we have
identified are related to metabolites of alcohol. Indeed,
previous work has shown in cultured cells that when alcohol metabolism is blocked by the addition of pyrazole,
impaired endocytosis by the hepatic ASGPR required
ethanol oxidation [50]. Additionally, our previous work
showed that in the presence of an inhibitor of aldehyde
dehydrogenase (cyanamide), that the impairments to
endocytosis were attenuated [51].

Conclusion
We provide evidence that the observed endocytosis and
vesicle protein content in AFLD animals are most likely
effects of ethanol metabolism in the liver which is not
seen in NAFLD.
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